Literature DB >> 9853421

Studies on Kochiae Fructus. V. Antipruritic effects of oleanolic acid glycosides and the structure-requirement.

H Matsuda1, Y Dai, Y Ido, T Murakami, H Matsuda1, M Yoshikawa, M Kubo.   

Abstract

We examined the antipruritic effects of various oleanolic acid glycosides from natural medicines such as Kochiae Fructus (the fruit of Kochia scoparia SCHRAD.) and Momordicae Radix (the roots of Momordica cochinchinensis SPRENG.) using a compound 48/80-induced pruritic model in mice. Oleanolic acid 3-O-monodesmosides showed an antipruritic effect, while oleanolic acid 3,28-O-bisdesmosides and their common sapogenol oleanolic acid lacked the activity. This evidence indicated that the 3-O-glycoside moiety and the 28-carboxyl group in oleanolic acid glycosides were essential for exhibiting the antipruritic effect. Furthermore, it was found that the 3-O-glucuronides showed more potent activity than the corresponding 3-O-glucosides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853421     DOI: 10.1248/bpb.21.1231

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Quantification Analysis and In Vitro Anti-Inflammatory Effects of 20-Hydroxyecdysone, Momordin Ic, and Oleanolic Acid from the Fructus of Kochia scoparia.

Authors:  Sae-Rom Yoo; Soo-Jin Jeong; Na-Ri Lee; Hyeun-Kyoo Shin; Chang-Seob Seo
Journal:  Pharmacogn Mag       Date:  2017-07-19       Impact factor: 1.085

Review 2.  Kochiae Fructus, the Fruit of Common Potherb Kochia scoparia (L.) Schrad: A Review on Phytochemistry, Pharmacology, Toxicology, Quality Control, and Pharmacokinetics.

Authors:  Wei Zou; Zhong Tang; Yao Long; Zuoqi Xiao; Bo Ouyang; Menghua Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-31       Impact factor: 2.629

3.  Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: a systematic review.

Authors:  Jason Jingjie Yu; Claire Shuiqing Zhang; Anthony Lin Zhang; Brian May; Charlie Changli Xue; Chuanjian Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.